Shattuck Labs, Inc. (NASDAQ:STTK) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Jeremy Green Other companies: Atara Biotherapeutics, Inc. (Director · Since at least May 16, 2025); Fate Therapeutics, Inc. (Director · Since at least Dec 15, 2017); LifeSci Acquisition II Corp (Director · Oct 6, 2021 – May 11, 2023 · Past); Absci Corporation (Director · Jul 21, 2021 – Jun 12, 2024 · Past); Medavail Holdings Inc (Director · Nov 17, 2020 – Jun 16, 2023 · Past); Augmedix Inc (Director · Oct 5, 2020 – Oct 2, 2024 · Past); IGM Biosciences Inc (Director · Sep 17, 2019 – Mar 31, 2025 · Past); Alder BioPharmaceuticals Inc (Director · Apr 25, 2018 – Oct 22, 2019 · Past) | Director · Since at least Oct 8, 2020 |
| Clay Siegall Other companies: Tourmaline Bio Inc. (Director · Since at least Dec 13, 2023); Immunome, Inc. (President & Chief Executive Officer · Since at least Oct 2, 2023); Nurix Therapeutics, Inc. (Director · May 28, 2021 – May 5, 2022 · Past); Synlogic Inc (Director · Sep 30, 2015 – Jun 29, 2016 · Past); Alder BioPharmaceuticals Inc (Director · May 7, 2014 – Oct 22, 2019 · Past); Ultragenyx Pharmaceutical Inc. (Director · Jan 30, 2014 – Aug 7, 2020 · Past); Seagen Inc (President & CEO, Director · Jan 31, 2006 – May 12, 2022 · Past) | President, Chairman of the Board of Immunome, Inc. · Since at least Mar 1, 2024 |
| George Golumbeski Other companies: Acumen Pharmaceuticals, Inc. (Chairman of its Board of Directors · Since at least Nov 6, 2025); Mural Oncology plc (Director · Since at least Jul 30, 2024); Sage Therapeutics Inc (Director · Since at least Jan 22, 2019); Corbus Pharmaceuticals Holdings, Inc. (Director · Jul 6, 2020 – Jul 6, 2020 · Past); Enanta Pharmaceuticals, Inc. (Director · Feb 7, 2014 – Feb 26, 2020 · Past); Acceleron Pharma Inc (Director · Sep 18, 2013 – Sep 18, 2013 · Past) | Director · Since at least Oct 8, 2020 |
| Helen M. Boudreau Other companies: Rallybio Corporation (Board Member · Since at least Jul 29, 2021); Tvardi Therapeutics, Inc. (Director · Aug 2, 2023 – Jun 4, 2024 · Past); Kineta Inc. (Chief Financial Officer · Feb 10, 2016 – Mar 1, 2018 · Past) | Director · Since at least Oct 8, 2020 |
| Neil Gibson Other companies: Instil Bio, Inc. (Board Member · Since at least Mar 18, 2021); Tcr2 Therapeutics Inc (Director · Feb 13, 2019 – Jun 1, 2023 · Past); Regulus Therapeutics Inc (Chief Scientific Officer · Oct 4, 2012 – Jan 28, 2015 · Past) | Director · Since at least Oct 8, 2020 |
| Daniel Baker Other companies: Artiva Biotherapeutics, Inc. (Director · Since at least Jan 28, 2025); Cue Biopharma, Inc. (CHIEF DEVELOPMENT OFFICER · Since at least Nov 25, 2024) | Director · Since at least Aug 25, 2025 |
| Michael Lee Other companies: IGM Biosciences Inc (Director · Since at least Sep 17, 2019); Fate Therapeutics, Inc. (Board Member · Since at least Jul 31, 2018) | Director · Since at least Oct 8, 2020 |
| Mona Ashiya Other companies: Disc Medicine, Inc. (Director · Since at least Dec 29, 2022); Sierra Oncology Inc (Director · Jun 8, 2021 – Jul 1, 2022 · Past) | Director · Since at least Aug 25, 2025 |
| Arundathy N Pandite Other companies: Codiak BioSciences Inc (Director · Aug 16, 2021 – Jun 17, 2022 · Past) | Chief Medical Officer · Since at least Oct 8, 2020 |
| Carrie Brownstein Other companies: Zentalis Pharmaceuticals, Inc. (Chief Medical Officer · Oct 3, 2022 – Oct 4, 2023 · Past) | Director · Since at least Oct 22, 2021 |
| Casi DeYoung Other companies: Synlogic Inc (Chief Business Officer · Sep 30, 2015 – Mar 11, 2016 · Past) | Chief Business Officer · Since at least Oct 8, 2020 |
| Abhinav A. Shukla | Chief Technical Officer · Since at least Apr 7, 2022 |
| Amy Franke | Vice President of Clinical Operations · Since at least Nov 4, 2026 |
| Amy Kate Sasser | Director · Since at least Mar 1, 2024 |
| Andrew R. Neill | Chief Financial Officer · Since at least Oct 8, 2020 |
| Brad Huckabee | Vice President of Accounting and SEC reporting · Since at least Nov 4, 2026 |
| Erin Ator Thomson | General Counsel · Oct 8, 2020 – Jan 25, 2023 · Past |
| Josiah Hornblower | Director · Oct 8, 2020 – Jul 15, 2021 · Past |
| Kelli Collin | Senior Vice President of Quality · Since at least Nov 4, 2026 |
| Lini Pandite | Chief Medical Officer · Since at least Jun 5, 2026 |
| Michael Choi | Vice President of Clinical Development · Since at least Jun 5, 2026 |
| Philip Jackson | Vice President of FP&A · Since at least Nov 4, 2026 |
| Shoba Ravichandran | Senior Vice President of Clinical Development · Since at least Oct 1, 2026 |
| Stephen Stout | General Counsel, Corporate Secretary and Chief Ethics and Compliance Officer · Since at least Mar 23, 2023 |
| Suresh de Silva | Chief Scientific Officer · Since at least Oct 13, 2026 |
| Taylor H. Schreiber | Chief Executive Officer, and Co-founder · Since at least Oct 8, 2020 |
| Thomas Lampkin | Senior Vice President of Regulatory Affairs · Since at least Nov 4, 2026 |
| Tyler Brous | Director · Since at least Oct 8, 2020 |
| Victor Stone | Director · Oct 8, 2020 – Oct 8, 2020 · Past |